Sat.Sep 04, 2021 - Fri.Sep 10, 2021

article thumbnail

AI could be used to guide drug therapy for heart failure

pharmaphorum

UK researchers have used artificial intelligence (AI) to develop a way to identify patients with heart failure who would benefit from treatment with beta blockers, by interrogating data from nine landmark clinical trials. The study applied machine learning to trial data involving 15,659 patients who were being treated for heart failure with reduced ejection fraction (HFrEF), a form of heart failure where the left side of the heart isn’t able to pump blood effectively around the body.

145
145
article thumbnail

Ginger's mental health app now available in Spanish with full rollout to all 25M users by early 2022

Fierce Healthcare

Ginger's mental health app now available in Spanish with full rollout to all 25M users by early 2022. hlandi. Fri, 09/10/2021 - 16:46.

131
131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacists must be mobilised to mitigate health impacts of air pollution

Pharma Mirror

The Hague, Pharmacists must be allowed to do more to manage respiratory conditions in communities if the urgent need to address the harmful effects of air pollution on health is to be met, the International Pharmaceutical Federation (FIP) said today. The expansion of pharmacists’ roles in mitigating the health threats of air pollution is among several actions described in a call to action issued by FIP, marking the United Nations International Day of Clean Air for Blue Skies.

98
article thumbnail

Intelligent digitalization can maximize manufacturing ROI: ACG

Outsourcing Pharma

A leader from ACG Engineering shares insight on how âsmartâ drug manufacturing, accelerated by COVID-19, can best be put to work now and in months to come.

104
104
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AI ‘could help diagnose lung cancer a year earlier’

pharmaphorum

An artificial intelligence algorithm was able to detect signs of lung cancer on CT scans a year earlier than with traditional methods, according to a new study. CT (computed tomography) scans are already used to spot signs of lung tumours, followed by a biopsy or surgery to confirm whether the tumour is malignant, according to Benoît Audelan, a researcher at France’s National Institute for Research in Digital Science and Technology.

Hospitals 110
article thumbnail

AHA concerned federal vaccine mandate could exacerbate severe worker shortage

Fierce Healthcare

AHA concerned federal vaccine mandate could exacerbate severe worker shortage. rking. Fri, 09/10/2021 - 16:09.

Vaccines 143

More Trending

article thumbnail

Neuroglee, Mayo Clinic partner on remote care management for Alzheimer’s

Outsourcing Pharma

The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimerâs.

article thumbnail

MHRA cuts could affect UK regulatory decisions, say unions

pharmaphorum

A 20% to 25% reduction in staffing at the UK Medicines and Healthcare products Regulatory Agency (MHRA) risks undermining the ability of the authority to fulfil its role, according to trade unions. In an open letter to Health Secretary Sajid Javid, Prospect, Unite and three other unions say the decision to slash the MHRA’s current 1,200 workforce by up to 300 workers means that “regulatory decisions may suffer.” Fewer staff will therefore be asked to cover more ground with fewe

101
101
article thumbnail

House lawmakers clash over impact of adding dental, vision and hearing benefits to Medicare

Fierce Healthcare

House lawmakers clash over impact of adding dental, vision and hearing benefits to Medicare. rking. Fri, 09/10/2021 - 15:52.

134
134
article thumbnail

IMPACT’S Making an IMPACT Initiative Celebrates the First Half of 2021

Impact Pharmaceutical Services

RESEARCH TRIANGLE PARK, NC: 30 August 2021 – In the first half of 2021, IMPACT’s employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. As we all continued to work from home, our virtual charitable and community outreach efforts took new and creative forms! Valentine’s Day Cards In February, MAI […].

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Recent FDA COVID-19 actions and updates

Outsourcing Pharma

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

FDA 83
article thumbnail

Startup Neuroglee raises $10m for virtual neurology clinics

pharmaphorum

A digital health company focusing on neurodegenerative disorders – Neuroglee Therapeutics – has raised $10 million in first-round funding to roll out a virtual neurology clinics for people with cognitive problems caused by dementia. The Singapore startup, which is partnering with the Mayo Clinic on the clinics, said the cash injection will also go towards the development of its pipeline of digital therapeutics (DTx) for Alzheimer’s disease and other neurodegenerative conditions.

article thumbnail

Chutes & Ladders—Allina Health's CEO to retire; Centene refreshes its executive team

Fierce Healthcare

Chutes & Ladders—Allina Health's CEO to retire; Centene refreshes its executive team. dmuoio. Thu, 09/09/2021 - 16:52.

135
135
article thumbnail

Blooming Through Life’s Changes with #LifeFlo

Dr. Jamie Hardy: The Lifestyle Pharmacist

Being 40 ish and feeling FABULOUS is the mantra that I live by. Sure, changes are happening in my body and life that I have no control over. However, the way I choose to live through those changes is UP TO ME. I can be joyful or judgmental. I can be motivated or mopey. I can even be grateful or gloomy. The choice really is mine. So, I’m choosing to see myself as a beautiful rose that continues to bloom no matter what comes my way.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

GSK rhinosinusitis drug receives thumbs up from the FDA

Outsourcing Pharma

Nucala, a monoclonal antibody indicated for patients with chronic rhinosinusitis with nasal polyps, has been approved by the Food and Drug Administration.

FDA 81
article thumbnail

Amgen builds case for severe asthma drug tezepelumab

pharmaphorum

Amgen and partner AstraZeneca have said their recently filed severe asthma drug tezepelumab has shown impressive results in patients who also have nasal polyps, a common complication of the respiratory disease. Tezepelumab reduced the annualised asthma exacerbation rate (AAER) by 86% in a subgroup of people with severe, uncontrolled asthma and polyps in the NAVIGATOR study, topping the 41% reduction achieved with the first-in-class TSLP inhibitor in the overall study population.

article thumbnail

Women’s health app Flo picks up $50M in fresh funding to fuel R&D, rapid growth

Fierce Healthcare

Women’s health app Flo picks up $50M in fresh funding to fuel R&D, rapid growth. elucas. Wed, 09/08/2021 - 12:54.

137
137
article thumbnail

DSH Risk, Advocate, and Hope it is not needed, Steps to Terminate

Turnkey Pharmacy Solutions

“One-Fourth of 340B DSH Hospitals at Risk of Losing Eligibility Due to Pandemic, Analysis Finds.” This is a shocking headline that recently caught my eye as I was perusing the 340B Report. The article further goes on to explain that an analysis of hospital Medicare cost reports for 2019 and 2020 show that about one.

article thumbnail

Qualified mobile research nurses key to DCT success: Illingworth

Outsourcing Pharma

A leader from Illingworth Research Group outlines exactly what makes a good mobile research nurse and what their duties in decentralized trials are.

83
article thumbnail

Mallinckrodt moves closer to resolving its opioid liability hangover

pharmaphorum

Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered drugmaker filed for bankruptcy last year, after proposing a $1.6 billion payout to settle lawsuits claiming that its marketing of opioid painkillers helped to fuel an epidemic in addiction that has claimed hundreds of thousands of lives in the US alone.

article thumbnail

HHS releases $25.5B in COVID-19 relief funding targeted at smaller providers

Fierce Healthcare

HHS releases $25.5B in COVID-19 relief funding targeted at smaller providers. rking. Fri, 09/10/2021 - 12:16.

139
139
article thumbnail

Sterling Pharma Solutions Establishes Centre of Excellence in Continuous Flow Chemistry

Pharma Mirror

Sterling Pharma Solutions, a global contract development and manufacturing organisation, today announced the completion of the initial phase of investment at its site in Dudley, UK to create the company’s centre of excellence for research into commercial applications of continuous flow chemistry. Announcement of the investment follows the appointment of Professor Ian R.

article thumbnail

Prepping for success can streamline transition to decentralized trials: Oracle

Outsourcing Pharma

According to an Oracle Health Sciences leader, companies looking to take on decentralized trials should keep a few things in mind before taking the plunge.

69
article thumbnail

Disparities between CEE and EU5 healthcare systems laid bare

pharmaphorum

Increasing public spending on healthcare in Central and Eastern Europe (CEE) could not only result in healthier populations, it could also improve the region’s economic prosperity. That’s according to a new report commissioned by the European Federation of Pharmaceutical Industry and Associations (EFPIA), which explores the health investment and outcomes.

article thumbnail

Employers put focus on integrating wellbeing into benefits, survey finds

Fierce Healthcare

Employers put focus on integrating wellbeing into benefits, survey finds. pminemyer. Thu, 09/09/2021 - 13:21.

136
136
article thumbnail

Provepharm Life Solutions raises €120 million

Pharma Mirror

Marseille, France, Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, today announces a €120 million ($142.3M) strategic funding. Tikehau Capital will provide the funds and joins the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.

article thumbnail

Increasingly savvy patients call for shift in trial approach: Illingworth

Outsourcing Pharma

A leader from the home trial services provder says patientsâ increasing awareness of clinical research has how trial teams should consider their approach.

61
article thumbnail

NICE changes its mind on J&J’s Erleada in prostate cancer

pharmaphorum

NICE has reversed its position on Johnson & Johnson’s oral prostate cancer therapy Erleada in patients with hormone-relapsed or hormone sensitive tumours, backing NHS use of the drug. The change of heart comes after J&J’s Janssen pharma unit offered an improved discount on Erleada (apalutamide), according to the cost-effectiveness watchdog in its final appraisal determination, which makes the drug an option for around 8,000 patients in England and Wales.

article thumbnail

Hospital telehealth visits leveling off at 10%-20% of appointments as claims hit lowest level since pandemic

Fierce Healthcare

Hospital telehealth visits leveling off at 10%-20% of appointments as claims hit lowest level since pandemic. hlandi. Thu, 09/09/2021 - 12:42.

Hospitals 115
article thumbnail

Controlled Substance Inventory Regulations

indispensable health

DEA Regulations For Controlled Substances Within Healthcare Settings The U.S. Department of Justice and the Drug Enforcement Administration (DEA) Regulate Controlled Substances Within Multiple Healthcare Settings These regulations require every healthcare setting (acute care facility, pharmacy, outpatient surgery center, long-term care facility, distributor, manufacturer, etc.) to complete a biennial controlled substance inventory.

article thumbnail

Getting the right tech tools vital to decentralized trial transition

Outsourcing Pharma

A representative from Cmed explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.

61
article thumbnail

Server cans autism hope bumetanide after phase 3 fails

pharmaphorum

Servier and Neurochlore have been forced to admit defeat in their bid to bring the first drug to market for people with autism spectrum disorder (ASD), after a comprehensive fail for their bumetanide candidate in two phase 3 trials. The French partners said today that there was “no sign of effectiveness” for bumetanide compared to placebo in 422 children and adolescents with ASD enrolled in the two studies, which have now been halted.

FDA 86
article thumbnail

SCAN Health Plan eyes expansion into Nevada, Arizona for 2022

Fierce Healthcare

SCAN Health Plan eyes expansion into Nevada, Arizona for 2022. pminemyer. Thu, 09/09/2021 - 14:36.

137
137
article thumbnail

Cryoviva Singapore Expands Cord Blood Banking Services to Bahrain

Pharma Mirror

Singapore, Local family cord blood bank Cryoviva Singapore ([link] is continuing with its rapid geographic growth plans with an entry into the Bahrain market. This latest new market entry closely follows Cryoviva establishing a footprint in Dubai to serve couples in the UAE that are on the family way. “It fills the entire Cryoviva team with a great sense of pride and satisfaction to help customers in Bahrain and add another nation to the list of countries we serve from Singapore.

52